【白云山:超10个创新药管线引进项目已完成立项】白云山在9月14日举行的2026年半年度业绩说明会上表示,目前公司建成管线项目库超100项,对接调研近50个BD创新药项目,其中超10个创新药管线引进项目已完成立项,治疗领域覆盖多个临床重点需求方向及前沿领域。公司将持续积极推进相关BD工作,并及时履行披露义务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.